|
11 |
A Comprehensive Review of Rapid-Onset Opioids for Breakthrough Pain
Enthalten in CNS drugs Bd. 26, 13.12.2012, Nr. 6, date:6.2012: 509-535
|
|
|
|
12 |
A Cost-Consequence Analysis of Pregabalin versus Usual Care in the Symptomatic Treatment of Refractory Low Back Pain
Enthalten in Clinical drug investigation Bd. 30, 29.8.2012, Nr. 8, date:8.2010: 517-531
|
|
|
|
13 |
A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five European countries
Enthalten in Applied health economics and health policy Bd. 10, 6.8.2012, Nr. 2, date:3.2012: 127-138
|
|
|
|
14 |
A Current Review of Juvenile Pemphigus Vulgaris
Enthalten in American journal of clinical dermatology Bd. 11, 10.9.2012, Nr. 1, date:2.2010: 21-33
|
|
|
|
15 |
A Decade of Safety-Related Regulatory Action in the Netherlands
Enthalten in Drug safety Bd. 33, 21.11.2012, Nr. 6, date:6.2010: 463-474
|
|
|
|
16 |
A Decision-Theoretic Framework for the Application of Cost-Effectiveness Analysis in Regulatory Processes
Enthalten in PharmacoEconomics Bd. 27, 17.9.2012, Nr. 8, date:8.2009: 645-655
|
|
|
|
17 |
A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data
Enthalten in PharmacoEconomics Bd. 29, 11.12.2012, Nr. 6, date:6.2011: 497-510
|
|
|
|
18 |
A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing
Enthalten in Applied health economics and health policy Bd. 10, 12.12.2012, Nr. 4, date:7.2012: 217-225
|
|
|
|
19 |
A Pharmacoepidemiological Network Model for Drug Safety Surveillance
Enthalten in Drug safety Bd. 35, 13.12.2012, Nr. 5, date:5.2012: 395-406
|
|
|
|
20 |
A Pharmacokinetic-Pharmacodynamic Model for Predicting the Impact of CYP2C9 and VKORC1 Polymorphisms on Fluindione and Acenocoumarol During Induction Therapy
Enthalten in Clinical pharmacokinetics Bd. 51, 13.9.2012, Nr. 1, date:1.2012: 41-53
|
|
Administration
